1. 1227PImmune-related adverse events (irAEs) predict therapeutic efficacy of an anti-PD-1 antibody in cancer patients. (23rd October 2018) Authors: Rogado, J; Romero Laorden, N; Sanchez Torres, J M; Ballesteros Garcia, A I; Pacheco-Barcia, V E; Arranz, R; Mondéjar Solís, R; Gullón, P; Lorenzo, A; Colomer Bosch, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 580PSafety and outcomes of self-expandable metal stents (SEMS) versus emergency surgery for acute colonic obstruction in metastatic colon cancer patients treated with bevacizumab (BV). (23rd October 2018) Authors: Pacheco-Barcia, V E; Mondéjar Solís, R; Martínez-Sáez, O; Longo, F; Bermejo, E; Moreno, J A; Marin, C; Correa, A; Maqueda, R; Rogado, J; García de Paredes, A; Rodriguez de Santiago, E; Pachón Olmos, V; Ferreiro Monteagudo, R; Rodriguez Garrote, M; Carrato Mena, A; Donnay, O; Martin Perez, E; Sant... Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 72OAddition of durvalumab (Dur) upon progression to bevacizumab (Bev) maintenance in advanced HER2-negative (HERNEG) breast cancer (BC): Safety, efficacy and biomarkers. (25th November 2018) Authors: Quintela-Fandino, M; Manso Sànchez, L M; Holgado Martín, E; Moreno, M C; Morales Murillo, S; Bermejo De Las Heras, B; Malon Gimenez, D; Colomer Bosch, R; Gonzalez Cortijo, L; Hornedo, J; Mouron, S; Muñoz, M; Escudero, S; Blanco, R; Mañes, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗